Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums

User menu

  • My alerts

Search

  • Advanced search
The College of Family Physicians of Canada
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums
  • My alerts
The College of Family Physicians of Canada

Advanced Search

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • RSS feeds
  • Follow cfp Template on Twitter
LetterCorrespondance

Not antagonist treatment

Robert Newman and Susan Gevertz
Canadian Family Physician November 2014, 60 (11) 986;
Robert Newman
New York, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan Gevertz
Scarsdale, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • eLetters
  • Info & Metrics
  • PDF
Loading

Regarding the article “Safety of the newer class of opioid antagonists in pregnancy,”1 the title of the article notwithstanding, its focus—the buprenorphinenaloxone combination—is not antagonist treatment. Rather, it is treatment with an opioid—buprenorphine—that has both agonist and antagonist properties, but a therapeutic effect due entirely to the former. With or without naloxone, buprenorphine is intended to eliminate or minimize withdrawal symptoms and establish a high degree of tolerance so that supplemental opioids will not produce euphoria, respiratory depression, sedation, etc. Precisely the same statement, of course, applies to methadone. The only rationale for adding the antagonist naloxone to buprenorphine is the hope that it will lessen the likelihood of misuse by parenteral routes of administration.2

The new data presented in the article do not seem to have relevance in deciding clinical management of opioid-dependent pregnant women. The experiences of only 10 babies are reported, 8 having been born to mothers taking maintenance therapy throughout pregnancy and 2 born to mothers for whom buprenorphinenaloxone was initiated during the first trimester. As the study was a retrospective chart review of live births, no information could be gathered regarding retention of the expectant mothers in treatment (retention for dependence or for prenatal care). This is an omission of particular importance, as the MOTHER (Maternal Opioid Treatment: Human Experimental Research) study, cited by the authors, reported that 33% of women who started taking buprenorphine dropped out before giving birth—almost 10% after the very first dose.3

It must also be noted that “[initial doses of] buprenorphine (and particularly buprenorphine/naloxone) can precipitate an opioid withdrawal syndrome if administered to a patient who is opioid dependent.”4 This is a particular concern when buprenorphine is initiated during pregnancy, as “[o] pioid withdrawal has been associated with poor fetal growth, preterm delivery, and fetal death.”5 The authors of the Motherisk article state at the outset that the “standard for managing opioid dependence in pregnant women is methadone maintenance.”1 Nothing in the article seems to challenge that conclusion.

Footnotes

  • Competing interests

    None declared

  • Copyright© the College of Family Physicians of Canada

References

  1. 1.↵
    1. Poon S,
    2. Pupco A,
    3. Koren G,
    4. Bozzo P
    . Safety of the newer class of opioid antagonists in pregnancy. Can Fam Physician 2014;60:631-2. (Eng), e348–9 (Fr).
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. US Food and Drug Administration.
    Subutex and suboxone questions and answers. Silver Spring, MD: US Food and Drug Administration; 2014. Available from: www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm191523.htm. Accessed 2014 Jul 22.
  3. 3.↵
    1. Jones HE,
    2. Kaltenbach K,
    3. Heil SH,
    4. Stine SM,
    5. Coyle MG,
    6. Arria AM,
    7. et al
    . Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Eng J Med 2010;363(24):2320-31.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Treatment protocols.
    Substance Abuse and Mental Health Services Administration. Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction. Treatment improvement protocol series, No. 40. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2004. Available from: www.ncbi.nlm.nih.gov/books/NBK64246/. Accessed 2014 Jul 22.
  5. 5.↵
    1. Dashe JS,
    2. Jackson GL,
    3. Olscher DA,
    4. Zane EH,
    5. Wendel GD Jr.
    . Opioid detoxification in pregnancy. Obstet Gynecol 1998;92(5):854-8.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Canadian Family Physician: 60 (11)
Canadian Family Physician
Vol. 60, Issue 11
1 Nov 2014
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on The College of Family Physicians of Canada.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Not antagonist treatment
(Your Name) has sent you a message from The College of Family Physicians of Canada
(Your Name) thought you would like to see the The College of Family Physicians of Canada web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Not antagonist treatment
Robert Newman, Susan Gevertz
Canadian Family Physician Nov 2014, 60 (11) 986;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Not antagonist treatment
Robert Newman, Susan Gevertz
Canadian Family Physician Nov 2014, 60 (11) 986;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Footnotes
    • References
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Methadone is methadone
  • Disappointed in platform
  • Power of words and expectation
Show more Correspondance

Similar Articles

Navigate

  • Home
  • Current Issue
  • Archive
  • Collections - English
  • Collections - Française

For Authors

  • Authors and Reviewers
  • Submit a Manuscript
  • Permissions
  • Terms of Use

General Information

  • About CFP
  • About the CFPC
  • Advertisers
  • Careers & Locums
  • Editorial Advisory Board
  • Subscribers

Journal Services

  • Email Alerts
  • Twitter
  • RSS Feeds

Copyright © 2021 by The College of Family Physicians of Canada

Powered by HighWire